CrossrefInfokarte
Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
Menopausal Review · 2022 · 21 (3) · 197-199
DOI: 10.5114/pm.2022.119861 ↗Abstract
Kein Abstract verfügbar.
EUVIMED